• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19、微血栓、炎症和血小板激活因子。

COVID-19, microthromboses, inflammation, and platelet activating factor.

机构信息

Laboratory of Biochemistry, Faculty of Chemistry, National & Kapodistrian University, Athens, Greece.

Laboratory of Biology, Biochemistry and Microbiology, Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.

出版信息

Biofactors. 2020 Nov;46(6):927-933. doi: 10.1002/biof.1696. Epub 2020 Dec 9.

DOI:10.1002/biof.1696
PMID:33296106
Abstract

Recent articles report elevated markers of coagulation, endothelial injury, and microthromboses in lungs from deceased COVID-19 patients. However, there has been no discussion of what may induce intravascular coagulation. Platelets are critical in the formation of thrombi and their most potent trigger is platelet activating factor (PAF), first characterized by Demopoulos and colleagues in 1979. PAF is produced by cells involved in host defense and its biological actions bear similarities with COVID-19 disease manifestations. PAF can also stimulate perivascular mast cell activation, leading to inflammation implicated in severe acute respiratory syndrome (SARS). Mast cells are plentiful in the lungs and are a rich source of PAF and of inflammatory cytokines, such as IL-1β and IL-6, which may contribute to COVID-19 and especially SARS. The histamine-1 receptor antagonist rupatadine was developed to have anti-PAF activity, and also inhibits activation of human mast cells in response to PAF. Rupatadine could be repurposed for COVID-19 prophylaxis alone or together with other PAF-inhibitors of natural origin such as the flavonoids quercetin and luteolin, which have antiviral, anti-inflammatory, and anti-PAF actions.

摘要

最近的文章报道了在死于 COVID-19 的患者的肺部中存在升高的凝血、内皮损伤和微血栓形成的标志物。然而,尚未讨论可能导致血管内凝血的原因。血小板在血栓形成中起着关键作用,其最有效的触发因素是血小板激活因子(PAF),Demopoulos 及其同事于 1979 年首次对其进行了描述。PAF 由参与宿主防御的细胞产生,其生物学作用与 COVID-19 疾病表现相似。PAF 还可以刺激血管周围肥大细胞的激活,导致与严重急性呼吸综合征(SARS)有关的炎症。肥大细胞在肺部中大量存在,是 PAF 和炎症细胞因子(如 IL-1β 和 IL-6)的丰富来源,这些细胞因子可能与 COVID-19 尤其是 SARS 有关。组胺 H1 受体拮抗剂 rupatadine 的开发具有抗 PAF 活性,并且还可以抑制 PAF 对人肥大细胞的激活。rupatadine 可以单独用于 COVID-19 的预防,也可以与其他天然来源的 PAF 抑制剂(如黄酮类 quercetin 和 luteolin)一起使用,这些抑制剂具有抗病毒、抗炎和抗 PAF 作用。

相似文献

1
COVID-19, microthromboses, inflammation, and platelet activating factor.COVID-19、微血栓、炎症和血小板激活因子。
Biofactors. 2020 Nov;46(6):927-933. doi: 10.1002/biof.1696. Epub 2020 Dec 9.
2
Coronavirus 2019, Microthromboses, and Platelet Activating Factor.新型冠状病毒 2019、微血栓和血小板激活因子。
Clin Ther. 2020 Oct;42(10):1850-1852. doi: 10.1016/j.clinthera.2020.08.006. Epub 2020 Aug 17.
3
Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor.芦曲班抑制人过敏性疾病实验室培养肥大细胞被血小板激活因子刺激后炎症介质的释放。
Ann Allergy Asthma Immunol. 2013 Dec;111(6):542-7. doi: 10.1016/j.anai.2013.08.025. Epub 2013 Sep 21.
4
Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).芦曲班特对血小板激活因子诱导的人肥大细胞脱颗粒作用的影响与地氯雷他定和左西替利嗪的比较(MASPAF 研究)。
J Investig Allergol Clin Immunol. 2017;27(3):161-168. doi: 10.18176/jiaci.0117. Epub 2016 Oct 19.
5
Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents.芦帕他定通过减轻 PAF 介导的衰老而预防肺纤维化。
PLoS One. 2013 Jul 15;8(7):e68631. doi: 10.1371/journal.pone.0068631. Print 2013.
6
Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).卢帕他定,一种新型强效的组胺和血小板活化因子(PAF)口服活性双重拮抗剂。
J Pharmacol Exp Ther. 1997 Jan;280(1):114-21.
7
COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.新型冠状病毒肺炎、肺肥大细胞、细胞因子风暴以及木犀草素的有益作用
Biofactors. 2020 May;46(3):306-308. doi: 10.1002/biof.1633. Epub 2020 Apr 27.
8
Clotting disorder in severe acute respiratory syndrome coronavirus 2.严重急性呼吸综合征冠状病毒 2 中的凝血障碍。
Rev Med Virol. 2021 May;31(3):e2177. doi: 10.1002/rmv.2177. Epub 2020 Oct 6.
9
Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.COVID-19 中的血小板病变与血小板高反应性:不同的病理、疾病结局和治疗意义。
Platelets. 2022 Jan 2;33(1):48-53. doi: 10.1080/09537104.2021.1961718. Epub 2021 Nov 30.
10
Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli.卢帕他定可抑制由不同刺激引发的人肥大细胞促炎介质分泌。
Int Arch Allergy Immunol. 2010;151(1):38-45. doi: 10.1159/000232569. Epub 2009 Aug 6.

引用本文的文献

1
Repurposing rupatadine to attenuate ovarian ischemia reperfusion in rats through modulation of PAF/NF-κB/TNF-α/IL-1β; HIF-1α/VEGF/Caspase 3 signaling pathways.通过调节PAF/NF-κB/TNF-α/IL-1β;HIF-1α/VEGF/Caspase 3信号通路,将卢帕他定重新用于减轻大鼠卵巢缺血再灌注损伤。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Sep 5. doi: 10.1007/s00210-025-04567-0.
2
Retinoic Acid Regulates Allergic Inflammation via Limiting Mast Cell Activation.视黄酸通过限制肥大细胞活化来调节过敏性炎症。
Food Sci Nutr. 2025 Jan 7;13(1):e4727. doi: 10.1002/fsn3.4727. eCollection 2025 Jan.
3
Hyperexpression of and as Possible Platelet Risk Biomarkers in Patients With COVID-19.
COVID-19 患者中血小板风险生物标志物 和 的过表达。
In Vivo. 2024 Nov-Dec;38(6):2853-2863. doi: 10.21873/invivo.13766.
4
Anti-Inflammatory and Neuroprotective Polyphenols Derived from the European Olive Tree, L., in Long COVID and Other Conditions Involving Cognitive Impairment.源自欧洲橄榄树的抗炎和神经保护多酚在长新冠和其他涉及认知障碍的疾病中的应用。
Int J Mol Sci. 2024 Oct 14;25(20):11040. doi: 10.3390/ijms252011040.
5
Role of micronutrients in the modulation of immune system and platelet activating factor in patients with COVID-19; a narrative review.微量营养素在调节2019冠状病毒病患者免疫系统和血小板活化因子中的作用;一项叙述性综述。
Front Nutr. 2023 Sep 15;10:1207237. doi: 10.3389/fnut.2023.1207237. eCollection 2023.
6
Rowanberry-A Source of Bioactive Compounds and Their Biopharmaceutical Properties.花楸果——生物活性化合物的来源及其生物制药特性
Plants (Basel). 2023 Sep 11;12(18):3225. doi: 10.3390/plants12183225.
7
COVID-19 and primary wound healing: A new insights and advance.新型冠状病毒肺炎与原发性伤口愈合:新的见解与进展。
Int Wound J. 2023 Dec;20(10):4422-4428. doi: 10.1111/iwj.14324. Epub 2023 Jul 24.
8
Correlation of vitamin D levels with serum parameters in Covid-19 patients.新型冠状病毒肺炎患者维生素 D 水平与血清学参数的相关性。
Clin Nutr ESPEN. 2023 Jun;55:325-331. doi: 10.1016/j.clnesp.2023.04.012. Epub 2023 Apr 19.
9
COVID-19, Blood Lipid Changes, and Thrombosis.新型冠状病毒肺炎、血脂变化与血栓形成
Biomedicines. 2023 Apr 15;11(4):1181. doi: 10.3390/biomedicines11041181.
10
Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions.衰老大脑与对新冠病毒的神经免疫反应:急性后遗症以及行为和营养干预的调节作用
Immun Ageing. 2023 Apr 12;20(1):17. doi: 10.1186/s12979-023-00341-z.